Literature DB >> 26282848

Aiweixin, a traditional Uyghur medicinal formula, protects against chromium toxicity in Caenorhabditis elegans.

Binggen Zhu1,2, Ping Yang3, Nurahmat Mammat4, Hui Ding5, Junmin He4,6, Yong Qian5, Jian Fei3,6, Kaiser Abdukerim7.   

Abstract

BACKGROUND: Aiweixin (AWX) is a traditional Uyghur medicine prescription, and has been mainly used to treat heart and brain diseases for a long time. Previous studies indicated that AWX had therapeutic effects in a rat model of myocardial ischemia reperfusion injury. In this study, we investigate whether AWX has protective effects against chromium toxicity in Caenorhabditis elegans (C. elegans).
METHODS: The AWX decoction was the conventional product for clinical use. It was added into M9 buffer in a certain volume for the treatment to the wild-type C. elegans and mutational worms, daf-16, glp-1(notch), daf-2, rsks-1 and eat-2. Assays for hexavalent chromium {Cr(VI)} stress and reactive oxygen species (ROS) production were used.
RESULTS: We found that AWX at moderate contents (0.083, 0.1, 0.125 volume of AWX/total volume) increased resistance of C. elegans to Cr(VI) exposure, although higher contents of AWX are toxic for C. elegans. The protective effect of AWX was DAF-16-dependent, but independent on the DAF-2, GLP-1, RSKS-1 and EAT-2. AWX (0.1 volume of AWX/total volume) significantly reduced ROS production of C. elegans induced by Cr(VI) exposure.
CONCLUSION: These results indicated the AWX protected against the toxicity of Cr(VI) in C. elegans, and the oxidative stress protective mechanism in worms should be involved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26282848      PMCID: PMC4539661          DOI: 10.1186/s12906-015-0783-4

Source DB:  PubMed          Journal:  BMC Complement Altern Med        ISSN: 1472-6882            Impact factor:   3.659


Background

Aiweixin (AWX) is a traditional Uyghur medicine prescription and consists of 15 ingredients including Dracocephalum moldavicum L., Eletteria cardamomum (L.) Maton, Salix caprea L. (Salicaceae) flowers, Lavandula augustifolia (lavender), Borago officinalis L. (Boraginaceae) stems and leaves, Borago officinalis L. (Boraginaceae) flower, Nardostachys jatamansi DC. root and rhizome (Nardostachyos Radix et Rhizoma), Bombyx mori (Abresham) silk cocoons, Usnea longissima Ach., Rosa rugosa Thunb. flowers, Syzygium aromaticum L., Lindera caudata (Nees) Hook.f., Myristica fragrans (Houtt.), Crocus sativus L. and Moschus [1]. AWX is orally administered as a decoction. According to the theory of traditional Uyghur medicine, AWX has preventive and treatment effects in many aspects, including modulating “Mizaj”, balancing body fluid, improving blood circulation, strengthening the function of heart and brain, etc. It has been used to treat diseases induced by abnormal “savda”, such as coronary heart disease, myocardial ischemia, arrhythmia, cerebral infarction, depression [1, 2]. The effectiveness of AWX has been well documented during long-term clinical practice. Previous pharmacological experiments demonstrated that AWX exerted therapeutic effects in a rat model of myocardial ischemia reperfusion injury, possibly via alleviation of oxidative stress [3, 4]. Chromium exists mostly in two valence states in nature: hexavalent chromium {Cr.(VI)} and trivalent chromium [5]. The trivalent chromium is essential for organisms, and is acknowledged as a dietary supplement. But the Cr(VI) and its compounds have been recognized as having potential severe adverse effects on health. Previous studies demonstrated that Cr(VI) induces oxidative stress, DNA damage, apoptotic cell death and altered gene expression [5-7]. The Caenorhabditis elegans (C. elegans), a free living nematode that lives mainly in the liquid phase of soils, is considered as an ideal model organism because of its short life span, ease of manipulation, and low cost. It has been found favor as a valuable bioindicator organism in metal toxicity study for its best-characterized properties at the genetic, physiological, molecular, and developmental levels [8, 9]. Assays using C. elegans to observe the lethality and sublethal endpoints, growth, reproduction, lifespan, locomotion behavior, stress response, and oxidative damage have been well developed to monitor the toxicity of heavy metals including Cr(VI) [8]. In the present study, we investigate whether AWX has protective effects against Cr(VI) toxicity in C. elegans, in order to get more preclinical data which support the therapeutic effects of AWX.

Methods

Preparation and phytochemical profile of AWX

The AWX decoction was the conventional product for clinical use, manufactured by Xinwei Pharmaceutical Factory (Hetian, Xinjiang Uyghur Autonomous Region, P. R. China). According to the Pharmacopeia of P. R. China [1], the product is made from Dracocephalum moldavicum L. (15 g), Eletteria cardamomum (L.) Maton (15 g), Salix caprea L. (Salicaceae) flowers (10 g), Lavandula augustifolia (lavender) (15 g), Borago officinalis L. (Boraginaceae) stems and leaves (10 g), Borago officinalis L. (Boraginaceae) flower (10 g), Nardostachys jatamansi DC. root and rhizome (Nardostachyos Radix et Rhizoma) (10 g), Bombyx mori (Abresham) silk cocoons (50 g), Usnea longissima Ach. (3 g), Rosa rugosa Thunb. flowers (15 g), Syzygium aromaticum L. (15 g), Lindera caudata (Nees) Hook.f. (10 g), Myristica fragrans (Houtt.) (15 g), Crocus sativus L. (0.6 g) and Moschus (0.2 g). The AWX decoction was prepared as follows: before 13 dry herbs were smashed into rude powder, decocted and boiled 3 times (1.5 h for each) while 300 ml of distilled water was collected. The decocted liquid merged the 300 ml of distilled water was filtrated, concentrated, and added with ethanol to 70 % the content of ethanol. The decoction was filtrated again after 24 h while ethanol was collected. Meanwhile, after the two dry medicinal materials was put in 70 % ethanol solution, were extracted by reflux two times (2 h for each). The extracted solution was filtrated while ethanol was collected. The former decoction and the latter extracted solution were mixed and added with distilled water to 1000 ml, then filtrated and sterilized. For the quality control of AWX decoction, high-performance liquid chromatography-diode array detection (HPLC-DAD) method has been used, referred to the previous paper [10]. The chromatographic separation was performed by a UItimate XB-C18 (250 mm × 4.6 mm, 5 μm) column in Agilent 1200 (Agilent Technologies). Mobile phase was a gradient of Methanol-acetic acid water gradient. The effluent was monitored on a DAD detector. The fingerprint was set up on the data at 280 nm. The Fig. 1 showed the HPLC fingerprint of three separated AWX samples. By using HPLC–UV-ESI-TOF-MS system, 4 peaks were recognized according to compound molecular weight data. The highest peak 1 contains chebulic acid, while peak 2–4 represent gallic acid, protocatechuic acid, and eugenol respectively. However, others (more than 10 low peaks) were unidentified.
Fig. 1

The HPLC fingerprint of three separated AWX samples. A, B and C represented three separated AWX samples

The HPLC fingerprint of three separated AWX samples. A, B and C represented three separated AWX samples

Caenorhabditis elegans strain and maintenance

The wild-type C. elegans strain N2 (Bristol) and mutational worms, daf-16 (mu86), glp-1(e2141), daf-2 (e1370), rsks-1 (ok1255) and eat-2 (ad465) were provided by the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN). Nematodes were generally incubated at 20 °C on nematode growth media (NGM) plates with E. coli OP50. For culture of daf-2 (e1370), and its wild-type control, nematodes were firstly developed at 16 °C for 3 days and then transferred to 21 °C for the desired stage of development.

Chromium stress assay and AWX treatment to C. elegans

The procedure of chromium stress assay was based on our previous studies [11]. Synchronized Day 3 adult worms were collected and washed with M9 buffer for three times to remove the OP50 bacteria. Approximately 35 adults were suspended into each well of a 48-well culture plate containing 120 μl M9 buffer with or without certain content of AWX (0.05, 0.067, 0.083, 0.1, 0.125 volume of AWX/total volume). 30 min later, K2Cr2O7 {Cr(VI), Sangon Biotech, Shanghai, China} was added at final concentration of 10 mM, except for the experiments without Cr(VI) exposure. The plates were cultivated at 20 °C for certain time. Survived nematodes were counted at different time points. The nematodes were judged to be dead if they did not respond to stimulus using a small, metal wire. Each experiment was reiterated for at least three times.

Reactive oxygen species (ROS) production

The method of worms received Cr(VI) exposure and treatment of AWX was same as above described in the chromium stress assay. The assay of ROS production was based on published studies [7]. The examined nematodes were transferred to 0.5 mL of M9 buffer containing 5 μM CM-H2DCFDA (Sigma-Aldrich, USA) and pre-incubated for 3 h at 20 °C, and then mounted on 2 % agar pads and examined with a fluorescence microscope (Nikon, SMZ 1500, Japan) at 480/40 nm of excitation wavelength and 535/50 nm of emission filter. Fluorescence levels were measured using Image Software (NIS-Elements D3.1) by determining average pixel intensity in each animal. More than 30 animals were counted for the statistical. The relative fluorescence intensities of the worm were semiquantified. The semi-quantified ROS was expressed as relative fluorescent units (RFU). Three replicates were performed.

Statistic

The results are reported as mean ± SEM. Significant differences between groups were tested by one-way analysis of variance (ANOVA) followed by Student’s t-test. Differences among multiple means were assessed by one-way ANOVA with Bonferroni correction. Statistical software OriginPro 7.5 was used (http://www.originlab.com/). Probability values less than or equal to 0.05 were considered statistically significant.

Results

High contents of AWX are toxic for C. elegans

All of synchronized day 3 adult worms used in our experiments survived well after 16 h incubation in M9 buffer without any additional compositions (seen the Fig. 2). Most (about 91.0 %) of worms were still in good condition after 23 h, but the overwhelming majority was not alive at 38 h incubation. To understand the basic effects of AWX for C. elegans, the toxicity and safety of AWX were assessed. As shown in Table 1, the mortality of C. elegans was increased with the elevation of AWX contents, after 16 h incubation. AWX at 0.1 volume of AWX/total volume was a little of toxicity (death ratio was 3/34, 8.8 %), but AWX at 0.2 and 0.333 were very toxic {death ratio was 37/46 (80.4 %) and 45/45 (100 %), respectively}. The worms incubated with AWX at 0.067 and 0.083 lived as well as the ones without the treatment of AWX.
Fig. 2

The survival measurement of wild-type C. elegans which did not receive any treatments

Table 1

Toxicity and safety of AWX for C. elegans

Contents of AWX (volume of AWX / total volume)
0 (control)0.0670.0830.10.20.333
Survival-16 h3849363190
Death-16 h00033745
Total384936344645
The survival measurement of wild-type C. elegans which did not receive any treatments Toxicity and safety of AWX for C. elegans

AWX increased resistance of C. elegans to Cr(VI) exposure in a time and dose-dependent manner

To investigate the protective effect of AWX against heavy metal Cr(VI) toxicity in C. elegans, chromium stress assay was used. As shown in Fig. 3, the survival fraction of the N2 adults' worm received AWX at o.1 was significantly higher than the control without treatment of AWX after 18 h (p < 0.01), 22.5 h (p < 0.01) and 24 h (p < 0.001) incubation. The similar effects of AWX at 0.083 and 0.125 were also seen, but not as strong as AWX at 0.1. The effects of AWX at 0.05 and 0.067 were not significant compared to the control. The significant enhanced effect at 24 h disappeared in the groups of AWX at 0.083 and 0.125, and was only observed in the group of AWX at 0.1. Moreover, according to the data in Fig. 2, most (about 91.0 %) of worms without any treatments were alive at 23 h, but about only 39.2 % of worms in the control to be exposure to Cr(VI) survived at near this time point (22.5 h) (seen the Fig. 3). In contrast, AWX at o.1 significantly elevated the fraction of survival worms roughly to 75.6 %.
Fig. 3

The AWX increased resistance of wild type C. elegans to heavy metal Cr(VI) exposure in a time and dose-dependent manner. The X-axis is hours, namely the time of treatment of AWX. The Y-axis is fraction of alive, that represented the fraction of worms which still lived after certain time. Control worms were exposure to Cr(VI) at 10 mM, but without the treatment of AWX. * and ※ P < 0.05, ** and ## P < 0.01, ### P <0.001 compared to control

The AWX increased resistance of wild type C. elegans to heavy metal Cr(VI) exposure in a time and dose-dependent manner. The X-axis is hours, namely the time of treatment of AWX. The Y-axis is fraction of alive, that represented the fraction of worms which still lived after certain time. Control worms were exposure to Cr(VI) at 10 mM, but without the treatment of AWX. * and ※ P < 0.05, ** and ## P < 0.01, ### P <0.001 compared to control

The protective effect of AWX was DAF-16-dependent

For further researches on the action of AWX, several of characterized mutant nematode lines were used. As Fig. 4 showed, AWX at 0.1 had significant protective effects on the wild-type worms after 16 h (p < 0.05), 18 h (p < 0.01), 20 h (p < 0.001) and 21 h (p < 0.001) incubation, but no significant influence on the mutational worm, daf-16 (mu86), implying that the DAF-16 function was essential for the action of AWX. However, experiments with other related mutant lines of worms, including glp-1(e2141), daf-2(e1370), rsks-1(ok1255) and eat-2(ad465), demonstrated protective effects of AWX as same as in the wild-type worms (seen in Fig. 5), indicating that the protective effect of AWX was independent on the function of GLP-1, DAF-2, RSKS-1, and EAT-2.
Fig. 4

The protective effect of AWX was not shown in the mutational worm, daf-16 (mu86). The meanings of X-axis and Y-axis are the same as ones in Fig. 2. Control worms were exposure to Cr(VI) at 10 mM, but without the treatment of AWX. AWX concentration was at 0.1 volume of AWX/total volume. * P < 0.05; ** P < 0.01; *** P <0.001 compared to wt-control. wt wild-type

Fig. 5

The protective effect of AWX was shown in the mutational worms, glp-1(e2141) (a), daf-2(e1370) (b), rsks-1(ok1255) (c) and eat-2(ad465) (d). The meanings of X-axis and Y-axis are the same as ones in Fig.2. Control worms were exposure to Cr (VI) at 10 mM, but without the treatment of AWX. AWX concentration was at 0.1 volume of AWX/total volume. * P < 0.05, ** P < 0.01, *** P < 0.001 compared to wt-control; # P < 0.05, ## P < 0.01, ### P < 0.001 compared to mutant-control respectively. wt, wild-type

The protective effect of AWX was not shown in the mutational worm, daf-16 (mu86). The meanings of X-axis and Y-axis are the same as ones in Fig. 2. Control worms were exposure to Cr(VI) at 10 mM, but without the treatment of AWX. AWX concentration was at 0.1 volume of AWX/total volume. * P < 0.05; ** P < 0.01; *** P <0.001 compared to wt-control. wt wild-type The protective effect of AWX was shown in the mutational worms, glp-1(e2141) (a), daf-2(e1370) (b), rsks-1(ok1255) (c) and eat-2(ad465) (d). The meanings of X-axis and Y-axis are the same as ones in Fig.2. Control worms were exposure to Cr (VI) at 10 mM, but without the treatment of AWX. AWX concentration was at 0.1 volume of AWX/total volume. * P < 0.05, ** P < 0.01, *** P < 0.001 compared to wt-control; # P < 0.05, ## P < 0.01, ### P < 0.001 compared to mutant-control respectively. wt, wild-type

AWX reduced ROS production of C. elegans induced by Cr(VI) exposure in a time-dependent manner

Chromium exposure increased the ROS production of nematodes [7]. To quantify whether AWX treatment decreases ROS levels elevated by Cr(VI) exposure in C. elegans, the ROS production was assayed.As shown in Fig. 6, treatment of AWX at 0.1 significantly compromised the density of fluorescent or the elevation of ROS production after 16 h and 19.5 h (p < 0.05 and p < 0.0005, respectively). Although the decreased effect was not significant at 14 h (p < 0.08), the effect of AWX appeared to begin early, and became stronger with the extension of incubation time, to some degree.
Fig. 6

ROS production of nematodes exposed to Cr (VI). (a) Pictures showing the ROS production as detected by CM-H2DCFDA labeling in nematodes exposed to Cr (VI) with or without AWX treatment. (b) Quantitative comparison of ROS production in nematodes exposed to Cr (VI) with or without AWX treatment. Control worms were exposure to Cr (VI) at 10 mM, but without AWX treatment. AWX concentration was at 0.1 volume of AWX/total volume

ROS production of nematodes exposed to Cr (VI). (a) Pictures showing the ROS production as detected by CM-H2DCFDA labeling in nematodes exposed to Cr (VI) with or without AWX treatment. (b) Quantitative comparison of ROS production in nematodes exposed to Cr (VI) with or without AWX treatment. Control worms were exposure to Cr (VI) at 10 mM, but without AWX treatment. AWX concentration was at 0.1 volume of AWX/total volume

Discussion

The toxicity of Cr(VI) for C. elegans is well documented [7–9, 12, 13]. AWX (a traditional Uyghur medicine prescription), for the first time, was studied for the treatment of Cr(VI) intoxication in C. elegans. We, using endpoints of lethality, found that AWX at moderate contents (0.083, 0.1, 0.125 volume of AWX/total volume) had protective effects against the toxicity of Cr(VI) in C. elegans, although AWX at higher concentrations (more than or equal to 0.1 volume of AWX/total volume) was toxic. The mechanistic cytotoxicity of Cr(VI) is not completely understand, however, a large number of studies demonstrated that Cr(VI) induces oxidative stress, DNA damage, apoptotic cell death and altered gene expression [5]. Concentration and time-dependent effects of Cr(VI) were demonstrated on increased ROS production and subsequent lipid peroxidation, enhanced excretion of urinary lipid metabolites, DNA fragmentation and apoptotic cell death in both in vitro and in vivo models [5]. According to our preliminary analysis regarding to the components of AWX, it contains chebulic acid, gallic acid, protocatechuic acid, and eugenol. Without exception, all of these compounds are potent antioxidants, by reviewing the literatures [14-18]. Moreover, considering that the AWX showed anti-oxidative effects in the previous studies in rats [3, 4], we supposed that AWX might protect the C. elegans from the oxidative damage induced by the Cr(VI). The experiment of ROS production demonstrated that AWX significantly reduced ROS production of C. elegans induced by Cr(VI) exposure. This result supports our hypothesis. The further indirect evidence comes from the studies used several mutant nematode strains. The effect of AWX was dependent on the DAF-16 function. The DAF-16 is a forkhead transcription factor, which integrates signals from multiple pathways and regulates its downstream target genes to control diverse processes [19, 20]. It is an important signal transducer of the insulin/IGF-1 signaling pathway, and it also receives input from several other pathways that regulate life span and the germline [19, 20]. Our further experiments demonstrated that the protective effect of AWX was independent on the functions of DAF-2 (insulin-IGF receptor), GLP-1(notch, regulating self-renewal and differentiation of germ stem cells), RSKS-1 (worm homolog of mammalian p70S6K, promoting cell cycle progression in the germ line) and EAT-2 (involving in life span control), implying that the insulin/IGF-1 pathway and pathways regulating life span (through diet restriction) and germline were not involved [21-24]. Therefore, the further pathway of AWX affecting on DAF-16 is not clear yet, and awaits further studies. While DAF-16 translocates into the nucleus, it binds dozens of target promoters of genes directly, and acts as an activator or a repressor of transcription. These genes participate in stress protection, the promotion or prevention of longevity, dauer formation/maintenance and fat storage [19, 20]. DAF-16 activates stress-response genes. The microarray and/or the bioinformatics studies disclosed that antioxidant genes (such as superoxide dismutase, metallothioneine, catalase, and glutathione S-transferase), and small heat shock protein genes are involved in the protective effects in worms [19, 20]. Therefore, the intensive researches of these downstream target genes of DAF-16 should be helpful to elucidate the molecular mechanisms of AWX.

Conclusions

In conclusion, AWX, a traditional Uyghur medicine prescription, had protective effects against the toxicity of Cr(VI) in C. elegans. As AWX suppressed ROS production of C. elegans induced by Cr(VI) exposure, and the protection was dependent on the DAF-16 function, the oxidative stress protective mechanism in worms should be involved.
  19 in total

1.  S6K links cell fate, cell cycle and nutrient response in C. elegans germline stem/progenitor cells.

Authors:  Dorota Z Korta; Simon Tuck; E Jane Albert Hubbard
Journal:  Development       Date:  2012-01-25       Impact factor: 6.868

Review 2.  Endocrine signaling in Caenorhabditis elegans controls stress response and longevity.

Authors:  Ralf Baumeister; Elke Schaffitzel; Maren Hertweck
Journal:  J Endocrinol       Date:  2006-08       Impact factor: 4.286

Review 3.  Worming pathways to and from DAF-16/FOXO.

Authors:  Arnab Mukhopadhyay; Seung Wook Oh; Heidi A Tissenbaum
Journal:  Exp Gerontol       Date:  2006-07-12       Impact factor: 4.032

4.  Toxicity evaluation in nematode Caenorhabditis elegans after chronic metal exposure.

Authors:  Lulu Shen; Jing Xiao; Huayue Ye; Dayong Wang
Journal:  Environ Toxicol Pharmacol       Date:  2009-03-24       Impact factor: 4.860

5.  Antiradical activity of gallic acid included in lipid interphases.

Authors:  C L Salcedo; M A Frías; A C Cutro; M A Nazareno; E A Disalvo
Journal:  Biochim Biophys Acta       Date:  2014-07-03

Review 6.  Scratching the niche that controls Caenorhabditis elegans germline stem cells.

Authors:  Dana T Byrd; Judith Kimble
Journal:  Semin Cell Dev Biol       Date:  2009-09-16       Impact factor: 7.727

7.  A C-terminal truncated mutation of spr-3 gene extends lifespan in Caenorhabditis elegans.

Authors:  Ping Yang; Ruilin Sun; Minghui Yao; Weidong Chen; Zhugang Wang; Jian Fei
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-05-21       Impact factor: 3.848

8.  Comparison of two mathematical prediction models in assessing the toxicity of heavy metal mixtures to the feeding of the nematode Caenorhabditis elegans.

Authors:  Jiandong Chen; Ying Jiang; Chi Xu; Li Yu; Dongye Sun; Li Xu; Feng Hu; Huixin Li
Journal:  Ecotoxicol Environ Saf       Date:  2013-05-28       Impact factor: 6.291

Review 9.  Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology.

Authors:  Maxwell C K Leung; Phillip L Williams; Alexandre Benedetto; Catherine Au; Kirsten J Helmcke; Michael Aschner; Joel N Meyer
Journal:  Toxicol Sci       Date:  2008-06-19       Impact factor: 4.849

Review 10.  A review on protocatechuic Acid and its pharmacological potential.

Authors:  Sahil Kakkar; Souravh Bais
Journal:  ISRN Pharmacol       Date:  2014-03-26
View more
  3 in total

1.  Effects of trypsin-induced limited hydrolysis on the structural, functional, and bioactive properties of sericin.

Authors:  Adil Omar; Yanhua Gao; Atikan Wubulikasimu; Amina Arken; Haji Akber Aisa; Abulimiti Yili
Journal:  RSC Adv       Date:  2021-07-21       Impact factor: 3.361

2.  Gengnianchun, a Traditional Chinese Medicine, Enhances Oxidative Stress Resistance and Lifespan in Caenorhabditis elegans by Modulating daf-16/FOXO.

Authors:  Fanhui Meng; Jun Li; Wenjun Wang; Yan Fu
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-16       Impact factor: 2.629

Review 3.  Notch signaling in cerebrovascular diseases (Review).

Authors:  Zhiyou Cai; Bin Zhao; Yanqing Deng; Shouqin Shangguan; Faming Zhou; Wenqing Zhou; Xiaoli Li; Yanfeng Li; Guanghui Chen
Journal:  Mol Med Rep       Date:  2016-08-19       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.